355423-48-2

Basic information

• Product Name: 5-Bromo-2,4-difluorophenol
• Synonyms: 5-Bromo-2,4-difluorophenol
• CAS NO: 355423-48-2
• Molecular Formula: C₆H₃BrF₂O
• Molecular Weight: 208.9882264
• Mol File: 355423-48-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 210.8±35.0 °C(Predicted)
• Appearance: /
• Density: 1.858±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 7.77±0.23(Predicted)
• CAS DataBase Reference: 5-Bromo-2,4-difluorophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2,4-difluorophenol(355423-48-2)
• EPA Substance Registry System: 5-Bromo-2,4-difluorophenol(355423-48-2)

Safety Data

• Hazardous Substances Data: 355423-48-2(Hazardous Substances Data)

Usage

General Description

5-Bromo-2,4-difluorophenol is a chemical compound with the molecular formula C6H3BrF2O. It is a phenolic compound with two fluorine atoms and one bromine atom attached to a phenol ring. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It also has applications in the field of material science and is used as a building block in the production of polymers and other industrial chemicals. Additionally, 5-Bromo-2,4-difluorophenol has been studied for its potential antimicrobial properties and its ability to inhibit the growth of certain microorganisms. Overall, this chemical compound has a wide range of potential applications in various industries due to its unique chemical properties.

Upstream product

• 28342-75-8 1,5-dibromo-2,4-difluorobenzene 
• 355423-44-8 bis(5-bromo-2,4-difluorophenyl) carbonate 

Downstream Products

• 943831-06-9 1-bromo-2,4-difluoro-5-methoxybenzene 

Relevant articles and documents

Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase

Free Energy Perturbation (FEP) calculations can provide high-confidence predictions of the interaction strength between a ligand and its protein target. We sought to explore a series of triazolopyrimidines which bind to the EED subunit of the PRC2 complex

PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS

The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.